- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
EntreMed Inc+ Add to Watchlist
ENMD:US1.5699 USD 0.0091 0.58%
As of 17:20:00 ET on 12/11/2013.
Company Profile for EntreMed Inc (ENMD)
EntreMed, Inc. researches and develops biopharmaceutical products that focus on the role of blood and blood vessels in health and disease. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. Therapeutics currently being researched include Endostatin and Angiostatin.
Key Executives for EntreMed Inc (ENMD)
|He Wei-WuChairman||Dwight L Bush SrVice Chairman|
|Ken K RenChief Executive Officer||Cynthia Wong HuVP/COO/Secy/General Counsel|
|Sara B CapitelliVP:Finance|